{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:07:43Z","timestamp":1784200063375,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"DOI":"10.1186\/s12871-026-04039-9","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:21:03Z","timestamp":1782184863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Individualized antibiotic therapy in patients with ventilator-associated pneumonia in the intensive care unit"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6140-2167","authenticated-orcid":false,"given":"Serhat","family":"Atalar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcrdal","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Ero\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130ftihar","family":"K\u00f6ksal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"5","key":"4039_CR1","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61\u2013111. https:\/\/doi.org\/10.1093\/cid\/ciw353.","journal-title":"Clin Infect Dis"},{"key":"4039_CR2","doi-asserted-by":"publisher","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. Eur Respir J. 2017;50:1700582. https:\/\/doi.org\/10.1183\/13993003.00582-2017.","journal-title":"Eur Respir J"},{"issue":"11","key":"4039_CR3","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1055\/a-2541-9872","volume":"79","author":"J Rademacher","year":"2025","unstructured":"Rademacher J, Ewig S, Grabein B, Nachtigall I, Abele-Horn M, Deja M, et al. Update der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie. Pneumologie. 2025;79(11):e3\u201357. https:\/\/doi.org\/10.1055\/a-2541-9872.","journal-title":"Pneumologie"},{"key":"4039_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13613-018-0444-0","volume":"8","author":"M Leone","year":"2018","unstructured":"Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, et al. Brief summary of French guidelines for the prevention, diagnosis and treatment of hospital-acquired pneumonia in ICU. Ann Intensive Care. 2018;8:104. https:\/\/doi.org\/10.1186\/s13613-018-0444-0.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"4039_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1378\/chest.122.1.262","volume":"122","author":"M Iregui","year":"2002","unstructured":"Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002;122(1):262\u20138. https:\/\/doi.org\/10.1378\/chest.122.1.262.","journal-title":"Chest"},{"issue":"2","key":"4039_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1378\/chest.115.2.462","volume":"115","author":"MH Kollef","year":"1999","unstructured":"Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115(2):462\u201374. https:\/\/doi.org\/10.1378\/chest.115.2.462.","journal-title":"Chest"},{"issue":"6","key":"4039_CR7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589\u201396. https:\/\/doi.org\/10.1097\/01.CCM.0000217961.75225.E9.","journal-title":"Crit Care Med"},{"issue":"19","key":"4039_CR8","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19):2588\u201398. https:\/\/doi.org\/10.1001\/jama.290.19.2588.","journal-title":"JAMA"},{"key":"4039_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007577.pub3","volume":"8","author":"R Pugh","year":"2015","unstructured":"Pugh R, Grant C, Cooke RP, Dempsey G. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev. 2015;8:CD007577. https:\/\/doi.org\/10.1002\/14651858.CD007577.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"4039_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/cc11899","volume":"17","author":"I Martin-Loeches","year":"2013","unstructured":"Martin-Loeches I, Torres A. A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia. Crit Care. 2013;17(1):106. https:\/\/doi.org\/10.1186\/cc11899.","journal-title":"Crit Care"},{"issue":"6","key":"4039_CR11","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s11096-021-01282-7","volume":"43","author":"YX Tan","year":"2021","unstructured":"Tan YX, Wong GW, Tan YH. Superinfection associated with prolonged antibiotic use in non-ventilator-associated hospital-acquired pneumonia. Int J Clin Pharm. 2021;43(6):1555\u201362. https:\/\/doi.org\/10.1007\/s11096-021-01282-7.","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"4039_CR12","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","volume":"177","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308\u201315. https:\/\/doi.org\/10.1001\/jamainternmed.2017.1938.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"4039_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13061333","volume":"13","author":"M Stoian","year":"2025","unstructured":"Stoian M, Azamfirei L, Andone A, V\u0103sie\u0219iu A-M, St\u00eengaciu A, Hu\u021banu A, et al. Incidence and risk factors of secondary infections in critically ill SARS-CoV-2 patients: a retrospective study in an intensive care unit. Biomedicines. 2025;13(6):1333. https:\/\/doi.org\/10.3390\/biomedicines13061333.","journal-title":"Biomedicines"},{"issue":"3","key":"4039_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics15030267","volume":"15","author":"M Stoian","year":"2026","unstructured":"Stoian M, Azamfirei L, St\u00e2ngaciu AC, Manea S, Onisor D, Manea A, et al. Six years of Acinetobacter species in critical care: carbapenem resistance and non-susceptibility, clinical outcomes, and lessons for stewardship. Antibiotics. 2026;15(3):267. https:\/\/doi.org\/10.3390\/antibiotics15030267.","journal-title":"Antibiotics"},{"issue":"5","key":"4039_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S2213-2600(23)00418-6","volume":"12","author":"Y Mo","year":"2024","unstructured":"Mo Y, Booraphun S, Li AY, Domthong P, Kayastha G, Lau YH, et al. Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial. Lancet Respir Med. 2024;12(5):399\u2013408. https:\/\/doi.org\/10.1016\/S2213-2600(23)00418-6.","journal-title":"Lancet Respir Med"},{"key":"4039_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101880","volume":"58","author":"MA Daghmouri","year":"2023","unstructured":"Daghmouri MA, Dudoignon E, Chaouch MA, Baekgaard J, Bougle A, Leone M, et al. Comparison of short versus long-course antibiotic therapy for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. EClinicalMedicine. 2023;58:101880. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101880.","journal-title":"EClinicalMedicine"},{"key":"4039_CR17","unstructured":"US Centers for Disease Control and Prevention, National Healthcare Safety Network. Pneumonia (ventilator-associated [VAP] and non-ventilator-associated pneumonia [PNEU]) event. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/6pscvapcurrent.pdf. Accessed May 5, 2026"},{"key":"4039_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154346","volume":"78","author":"HA Cheema","year":"2023","unstructured":"Cheema HA, Ellahi A, Hussain HU, Kashif H, Adil M, Kumar D, et al. Short-course versus prolonged-course antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. J Crit Care. 2023;78:154346. https:\/\/doi.org\/10.1016\/j.jcrc.2023.154346.","journal-title":"J Crit Care"},{"issue":"7","key":"4039_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00134-022-06690-5","volume":"48","author":"A Bougl\u00e9","year":"2022","unstructured":"Bougl\u00e9 A, Tuffet S, Federici L, Leone M, Monsel A, Dessalle T, et al. Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial. Intensive Care Med. 2022;48(7):841\u20139. https:\/\/doi.org\/10.1007\/s00134-022-06690-5.","journal-title":"Intensive Care Med"},{"issue":"9713","key":"4039_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375(9713):463\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(09)61879-1.","journal-title":"Lancet"},{"issue":"7","key":"4039_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16(7):819\u201327. https:\/\/doi.org\/10.1016\/S1473-3099(16)00053-0.","journal-title":"Lancet Infect Dis"},{"key":"4039_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30592-3","author":"P Schuetz","year":"2017","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2017. https:\/\/doi.org\/10.1016\/S1473-3099(17)30592-3.","journal-title":"Lancet Infect Dis"},{"key":"4039_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2125-7","volume":"22","author":"Y Wirz","year":"2018","unstructured":"Wirz Y, Meier MA, Bouadma L, Luyt CE, Wolff M, Chastre J, et al. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Crit Care. 2018;22:191. https:\/\/doi.org\/10.1186\/s13054-018-2125-7.","journal-title":"Crit Care"},{"issue":"3","key":"4039_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/10600280251355630","volume":"60","author":"AS Huang","year":"2026","unstructured":"Huang AS, Zhao JJ, Gumbleton R, Scipione MR. Early clinical response is associated with a decreased risk of recurrent Pseudomonas aeruginosa ventilator-associated pneumonia. Ann Pharmacother. 2026;60(3):221\u20138. https:\/\/doi.org\/10.1177\/10600280251355630.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"4039_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4103\/0019-5049.72643","volume":"54","author":"H Gadani","year":"2010","unstructured":"Gadani H, Vyas A, Kar AK. A study of ventilator-associated pneumonia: incidence, outcome, risk factors and measures for prevention. Indian J Anaesth. 2010;54(6):535\u201340. https:\/\/doi.org\/10.4103\/0019-5049.72643.","journal-title":"Indian J Anaesth"},{"issue":"6","key":"4039_CR26","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1164\/ajrccm.163.6.2007020","volume":"163","author":"PJ Dennesen","year":"2001","unstructured":"Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med. 2001;163(6):1371\u20135. https:\/\/doi.org\/10.1164\/ajrccm.163.6.2007020.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"4039_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/01.CCM.0000055380.86458.1E","volume":"31","author":"CM Luna","year":"2003","unstructured":"Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med. 2003;31(3):676\u201382. https:\/\/doi.org\/10.1097\/01.CCM.0000055380.86458.1E.","journal-title":"Crit Care Med"},{"issue":"7","key":"4039_CR28","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/cid\/ciw870","volume":"64","author":"M Klompas","year":"2016","unstructured":"Klompas M, Li L, Menchaca JT, Gruber S. Ultra-short-course antibiotics for patients with suspected ventilator-associated pneumonia but minimal and stable ventilator settings. Clin Infect Dis. 2016;64(7):870\u20136. https:\/\/doi.org\/10.1093\/cid\/ciw870.","journal-title":"Clin Infect Dis"},{"key":"4039_CR29","unstructured":"Light, R. B., Mink, S. N., Cooligan, T. G., & Wood, L. D. (1983). The physiology of recovery in experimental pneumococcal pneumonia. PubMed, 6(3), 147\u2013151. https:\/\/pubmed.ncbi.nlm.nih.gov\/6652981"},{"issue":"1","key":"4039_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1164\/rccm.200406-746OC","volume":"171","author":"CE Luyt","year":"2005","unstructured":"Luyt CE, Gu\u00e9rin V, Combes A, Trouillet JL, Ayed SB, Bernard M, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2005;171(1):48\u201353.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"4039_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1121","volume":"143","author":"J Pugin","year":"1991","unstructured":"Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143(5):1121\u20139. https:\/\/doi.org\/10.1164\/ajrccm\/143.5_Pt_1.1121.","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"4039_CR32","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3390\/children11050592","volume":"11","author":"J Becerra-Herv\u00e1s","year":"2024","unstructured":"Becerra-Herv\u00e1s J, Guitart C, Covas A, Bobillo-P\u00e9rez S, Rodr\u00edguez-Fanjul J, Carrasco-Jordan JL, et al. The clinical pulmonary infection score combined with procalcitonin and lung ultrasound (CPIS-PLUS) for early diagnosis of ventilator-associated pneumonia in pediatrics. Children (Basel). 2024;11(5):592. https:\/\/doi.org\/10.3390\/children11050592.","journal-title":"Children (Basel)"},{"key":"4039_CR33","doi-asserted-by":"publisher","first-page":"175346661876013","DOI":"10.1177\/1753466618760134","volume":"12","author":"P Wongsurakiat","year":"2018","unstructured":"Wongsurakiat P, Tulatamakit S. Clinical pulmonary infection score and procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia. Ther Adv Respir Dis. 2018;12:1753466618760134. https:\/\/doi.org\/10.1177\/1753466618760134.","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"4039_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1099\/jmm.0.000401","volume":"66","author":"G Yilmaz","year":"2017","unstructured":"Yilmaz G, Salyan S, Aksoy F, K\u00f6ksal \u0130. Individualized antibiotic therapy in patients with ventilator-associated pneumonia. J Med Microbiol. 2017;66(1):78\u201382. https:\/\/doi.org\/10.1099\/jmm.0.000401.","journal-title":"J Med Microbiol"},{"issue":"10","key":"4039_CR35","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/CCM.0b013e31828e969f","volume":"41","author":"CF Oliveira","year":"2013","unstructured":"Oliveira CF, Botoni FA, Oliveira CR, Silva CB, Pereira HA, Serufo JC, et al. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis. Crit Care Med. 2013;41(10):2336\u201343. https:\/\/doi.org\/10.1097\/CCM.0b013e31828e969f.","journal-title":"Crit Care Med"},{"issue":"5","key":"4039_CR36","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1183\/09031936.05.00071704","volume":"25","author":"P P\u00f3voa","year":"2005","unstructured":"P\u00f3voa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J. 2005;25(5):804\u201312. https:\/\/doi.org\/10.1183\/09031936.05.00071704.","journal-title":"Eur Respir J"},{"issue":"5","key":"4039_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/cc5036","volume":"10","author":"R Seligman","year":"2006","unstructured":"Seligman R, Meisner M, Lisboa TC, Hertz FT, Filippin TB, Fachel JM, et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care. 2006;10(5):R125. https:\/\/doi.org\/10.1186\/cc5036.","journal-title":"Crit Care"},{"issue":"9","key":"4039_CR38","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1097\/01.CCM.0000277042.31524.66","volume":"35","author":"K Agbaht","year":"2007","unstructured":"Agbaht K, Diaz E, Mu\u00f1oz E, Lisboa T, Gomez F, Depuydt PO, et al. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia*: Crit Care Med. 2007;35(9):2064\u201370. https:\/\/doi.org\/10.1097\/01.CCM.0000277042.31524.66.","journal-title":"Crit Care Med"},{"issue":"6","key":"4039_CR39","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/SHK.0b013e3181cc0418","volume":"33","author":"II Siempos","year":"2010","unstructured":"Siempos II, Vardakas KZ, Kyriakopoulos CE, Ntaidou TK, Falagas ME. Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis. Shock. 2010;33(6):590\u2013601. https:\/\/doi.org\/10.1097\/SHK.0b013e3181cc0418.","journal-title":"Shock"},{"issue":"3","key":"4039_CR40","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.chest.2020.03.087","volume":"158","author":"EJ Zasowski","year":"2020","unstructured":"Zasowski EJ, Bassetti M, Blasi F, Goossens H, Rello J, Sotgiu G, et al. A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections. Chest. 2020;158(3):929\u201338. https:\/\/doi.org\/10.1016\/j.chest.2020.03.087.","journal-title":"Chest"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-026-04039-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-04039-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-04039-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:09:36Z","timestamp":1784196576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12871-026-04039-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4039"],"URL":"https:\/\/doi.org\/10.1186\/s12871-026-04039-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9269769\/v1","asserted-by":"object"}]},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Karadeniz Technical University Faculty of Medicine Scientific Research Ethics Committee (Protocol No: 2018\/142; Decision No: 24237859\u2013608). All procedures performed in this study involving human participants were conducted in accordance with the ethical standards of the institutional research committee and with the principles of the Declaration of Helsinki and its subsequent amendments.Due to the retrospective nature of this study and the use of de-identified data, the requirement for written informed consent to participate was explicitly waived by the Karadeniz Technical University Faculty of Medicine Scientific Research Ethics Committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"429"}}